|
Influenza Viral Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
Influenza Viral Pathogenesis
|
|
Inhibition Of Renal Injury
|
Research Initiative
|
FDA
|
NIDDK
|
Inhibition Of Renal Injury
|
|
Innovation Equity Forum Steering Committee (IEF SteerCo)
|
Research Initiative
|
FDA
|
OD/DPCPSI/ORWH, OD, NICHD, NHLBI, NINDS, NIGMS, FIC, NCATS, NIA, NCCIH
|
1. Convene a global community of key stakeholders and gatekeepers of health innovation around women health R&D (e.g., funders, researchers, and community partners) 2. Mobilize and accelerate innovations to improve women health through shared understanding of critical womens health R&D priorities (where possible based on existing blueprints) 3. Foster cross-sector multinational partnerships to advance R&D efforts in womens health innovation through enhanced coordination and collaboration
|
|
Integrated Research Facility at Fort Detrick
|
Research Initiative
|
FDA
|
NIAID
|
Integrated Research Facility at Fort Detrick
|
|
Inter-Agency Working Group on the National Healthcare Quality and Disparities Report
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS, ASPE, FDA
|
NIMHD, NCI, NHLBI, OD/DPCPSI
|
This working group provides expert scientific guidance for the National Healthcare Quality and Disparities Report. These annual reports measure trends in effectiveness of care, patient safety, timeliness of care, patient centeredness, and efficiency of care. The reports present, in chart form, the latest available findings on quality of and access to health care.
|
|
Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NHGRI, CC, NCATS, NCI, NEI, NIAAA, NICHD, NLM, NIA
|
This education collaborative facilitates sharing interactions among professional societies, agencies, and health systems. It intends to enhance the accrual of knowledge and skill among practitioners applying genomic results to clinical care. In its start-up phase, the ISCC-PEG focused primarily on physicians and dentists. It has since expanded to engage and collaborate with allied practitioner groups such as nurse practitioners, physician assistants, pharmacists, genetic counselors, and nurses comprising integrated health care teams. It will continue to add other relevant professions and add to the reviewed and searchable educational resources on its website.
|
|
Interagency Adult Literacy Research Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF
|
NICHD
|
This is an intra-government, trans-agency group shares updates on research relevant to adults with lower literacy skills (i.e., reading and writing) as well as practices and programs that are being implemented to assist these learners in various agencies. The goal is for staff and corresponding agencies to be informed of broader efforts occurring around adult literacy within the federal government and to keep abreast of research and promising programs that might inform their work.
|
|
Interagency Agreement NTP/NIEHS and NCTR/FDA (IAA)
|
Other
|
FDA
|
NIEHS
|
Collaborative working relationship between NTP/NIEHS and NCTR/FDA
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDDK, NIBIB, NICHD
|
The Interagency Artificial Pancreas Working Group is a group of multi-disciplined scientists and clinicians from the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) to support the Artificial Pancreas Initiative. The goals of this initiative are to provide infrastructure for narrowing the gap between basic biomedical knowledge and clinical application of novel technologies, and to cross-fertilize and partner with stakeholders in order to identify and overcome the clinical and scientific challenges to the development of an artificial pancreas. Through collaborative efforts, such as workshops, the group strives to develop innovative strategies to achieve their goals.
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIMH, NICHD, NIEHS, NINDS, NIDCD, OD
|
The Interagency Autism Coordinating Committee (IACC) is a federal advisory committee charged with coordinating federal activities concerning autism spectrum disorder (ASD) and providing advice to the Secretary of Health and Human Services on issues related to autism. Membership of the Committee includes a wide array of federal departments and agencies involved in ASD research and services, as well as public stakeholders, including self-advocates, family members of children and adults with ASD, advocates, service providers, and researchers, who represent a variety of perspectives from within the autism community. The Committee members myriad expertise and experience aim to equip the IACC to address the wide range of issues and challenges faced by individuals and families affected by autism. The IACC was reauthorized under the Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act of 2019. In fiscal year 2022, the IACC held three full committee meetings on: October 13-14, 2021; January 19, 2022; and April 13-14, 2022.
|